Cercare il medicinale per il nome

Timolol and hydrochlorothiazide e Diabete

Risultato del controllo d'interazione tra il farmaco Timolol and hydrochlorothiazide e la malattia Diabete su sicurezza in caso d'uso simultaneo.

Risultato di controllo:

Timolol and hydrochlorothiazide <> Diabete

Rilevanza: 23.07.2019 Recensore: P.M. Shkutko, dott., in

Durante il controllo d'interazione, secondo le fonti autorevoli Drugs.com, Rxlist.com, Webmd.com, Medscape.com sono trovate le controindicazioni o gli effetti collaterali che possono danneggiare oppure intensificare l’effetto negativo in caso d'uso del farmaco in presenza di questa malattia concomitante.

Consumatore:

Dei recettori Beta-adrenergici agenti di blocco (aka beta-bloccanti) può mascherare i sintomi di ipoglicemia come tremori, tachicardia e variazioni della pressione sanguigna. Inoltre, il selettivi beta-bloccanti (es. propranololo, pindololo, timololo) possono inibire l'azione delle catecolamine-mediata glicogenolisi, quindi cumulo di insulina indotta da ipoglicemia e ritardare il ripristino di normali livelli di glucosio nel sangue. Dal cardioselectivity non è assoluta, grandi dosi di beta-1 selettivo agenti possono dimostrare di questi effetti. La terapia con beta-bloccanti devono essere somministrati con cautela in pazienti con diabete o predisposti a ipoglicemia spontanea.

Fonte

"Product Information. Kerlone (betaxolol)." Searle, Skokie, IL.
"Product Information. Lopressor (metoprolol)." Novartis Pharmaceuticals, East Hanover, NJ.
"Product Information. Inderal (propranolol)." Wyeth-Ayerst Laboratories, Philadelphia, PA.
"Product Information. Zebeta (bisoprolol)." Lederle Laboratories, Wayne, NJ.
"Product Information. Cartrol (carteolol)." Abbott Pharmaceutical, Abbott Park, IL.
Grimaldi A, Bennett P, Delas B, et al "Beta-blockers and hypoglycaemia: assessment of cardioselective and intrinsic sympathomimetic properties in relation to severity of hypoglycaemia." Curr Ther Res Clin Exp 36 (1984): 361-73
"Product Information. Sectral (acebutolol)." Wyeth-Ayerst Laboratories, Philadelphia, PA.
"Product Information. Blocadren (timolol)." Merck & Co, Inc, West Point, PA.
"Product Information. Trandate (labetalol)." Glaxo Wellcome, Research Triangle Park, NC.
"Product Information. Visken (pindolol)." Sandoz Pharmaceuticals Corporation, East Hanover, NJ.
Darga LL, Hakim MJ, Lucas CP, Franklin BA "Comparison of the effects of guanadrel sulfate and propranolol on blood pressure, functional capacity, serum lipoproteins and glucose in systemic hypertension." Am J Cardiol 67 (1991): 590-6
Velde TM, Kaiser FE "Ophthalmic timolol treatment causing altered hypoglycemic response in a diabetic patient." Arch Intern Med 143 (1983): 1627
Giugliano D, Acampora R, Marfella R, DeRosa N, Ziccardi P, Ragone R, DeAngelis L, DOnofrio F "Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension - A randomized, controlled trial." Ann Intern Med 126 (1997): 955-9
"Product Information. Levatol (penbutolol)." Reed and Carnrick, Jersey City, NJ.
"Product Information. Brevibloc (esmolol)." DuPont Pharmaceuticals, Wilmington, DE.
"Product Information. Coreg (carvedilol)." SmithKline Beecham, Philadelphia, PA.
"Product Information. Normodyne (labetalol)." Schering Laboratories, Kenilworth, NJ.
"Product Information. Tenormin (atenolol)." ICN Pharmaceuticals Inc, Cost Mesa, CA.
"Product Information. Corgard (nadolol)." Bristol-Myers Squibb, Princeton, NJ.
Uusitupa M, Aro A, Pietikainen M "Severe hypoglycaemia caused by physical strain and pindolol therapy." Ann Clin Res 12 (1980): 25-7
"Product Information. Betapace (sotalol)." Berlex, Richmond, CA.

Timolol and hydrochlorothiazide

Nome generico: hydrochlorothiazide / timolol

Marchio commerciale:

Sinonimo: Timolol and hydrochlorothiazide (Oral)

Cos`è Timolol and hydrochlorothiazide?

Altro farmaco Elimina

Timolol and hydrochlorothiazide <> Diabete

Rilevanza: 23.07.2019 Recensore: P.M. Shkutko, dott., in

Consumatore:

I diuretici tiazidici possono causare iperglicemia e glicosuria in pazienti con diabete. Essi possono anche precipitare il diabete in pazienti prediabetici. Questi effetti sono di solito reversibili dopo l'interruzione dei farmaci. La terapia con diuretici tiazidici devono essere somministrati con cautela in pazienti con diabete mellito, intolleranza al glucosio, o una predisposizione all'iperglicemia. I pazienti con diabete mellito devono essere monitorati più attentamente durante la terapia con tiazidici, e la loro antidiabetici regime regolato di conseguenza.

Fonte

Nielsen S, Schmitz A, Knudsen RE, Dollerup J, Mogensen CE "Enalapril versus bendroflumethiazide in type 2 diabetes complicated by hypertension." Q J Med 87 (1994): 747-54
Diamond MT "Hyperglycemic hyperosmolar coma associated with hydrochlorothiazide and pancreatitis." N Y State J Med 72 (1972): 1741-2
Blayac JP, Ribes G, Buys D, Puech R, Loubatieres-Mariani MM "Effects of a new benzothiadiazine derivative, LN 5330, on insulin secretion." Arch Int Pharmacodyn Ther 253 (1981): 154-63
Pickkers P, Schachter M, Hughes AD, Feher MD, Sever PS "Thiazide-induced hyperglycaemia: a role for calcium-activated potassium channels?" Diabetologia 39 (1996): 861-4
Andersen OO, Persson I "Carbohydrate metabolism during treatment with chlorthalidone and ethacrynic acid." Br Med J 2 (1968): 798-801
Petri M, Cumber P, Grimes L, Treby D, Bryant R, Rawlins D, Ising H "The metabolic effects of thiazide therapy in the elderly: a population study." Age Ageing 15 (1986): 151-5
"Product Information. Renese-R (reserpine-polythiazide)." Pfizer US Pharmaceuticals, New York, NY.
"Product Information. Thalitone (chlorthalidone)." Monarch Pharmaceuticals Inc, Bristol, TN.
Berglund G, Andersson O, Widgren B "Low-dose antihypertensive treatment with a thiazide diuretic is not diabetogenic. A 10-year controlled trial with bendroflumethiazide." Acta Med Scand 220 (1986): 419-24
"Product Information. Enduron (methyclothiazide)." Abbott Pharmaceutical, Abbott Park, IL.
Berlin I "Prazosin, diuretics, and glucose intolerance." Ann Intern Med 119 (1993): 860
Pollare T, Lithell H, Berne C "A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension." N Engl J Med 321 (1989): 868-73
Bell DS "Insulin resistance. An often unrecognized problem accompanying chronic medical disorders." Postgrad Med 93 (1993): 99-103,
Murphy MB, Kohner E, Lewis PJ, Schumer B, Dollery CT "Glucose intolerance in hypertensive patients treated with diuretics: a fourteen-year follow-up." Lancet 2 (1982): 1293-5
"Product Information. Zaroxolyn (metolazone)." Rhone-Poulenc Rorer, Collegeville, PA.
Goldman JA, Neri A, Ovadia J, Eckerling B, Vries A, de "Effect of chlorothiazide on intravenous glucose tolerance in pregnancy." Am J Obstet Gynecol 105 (1969): 556-60
Freis ED "The efficacy and safety of diuretics in treating hypertension." Ann Intern Med 122 (1995): 223-6
Schmitz O, Hermansen K, Nielsen OH, Christensen CK, Arnfred J, Hansen HE, Mogensen CE, Orskov H, Beck-Nielsen H "Insulin action in insulin-dependent diabetics after short-term thiazide therapy." Diabetes Care 9 (1986): 631-6
Rowe P, Mather H "Hyperosmolar non-ketotic diabetes mellitus associated with metolazone." Br Med J 291 (1985): 25-6
Chowdhury FR, Bleicher SJ "Chlorthalidone--induced hypokalemia and abnormal carbohydrate metabolism." Horm Metab Res 2 (1970): 13-6
Winchester JF, Kellett RJ, Boddy K, Boyle P, Dargie HJ, Mahaffey ME, Ward DM, Kennedy AC "Metolazone and bendroflumethiazide in hypertension: physiologic and metabolic observations." Clin Pharmacol Ther 28 (1980): 611-8
Slotkoff L "Clinical efficacy and safety of indapamide in the treatment of edema." Am Heart J 106 (1983): 233-7
Harper R, Ennis CN, Heaney AP, Sheridan B, Gormley M, Atkinson AB, Johnston GD, Bell PM "A comparison of the effects of low- and conventional-dose thiazide diuretic on insulin action in hypertensive patients with NIDDM." Diabetologia 38 (1995): 853-9
Beling S, Vukovich RA, Neiss ES, Zisblatt M, Webb E, Losi M "Long-term experience with indapamide." Am Heart J 106 (1983): 258-62
"Product Information. Diucardin (hydroflumethiazide)." Wyeth-Ayerst Laboratories, Philadelphia, PA.
Curtis J, Horrigan F, Ahearn D, Varney R, Sandler SG "Chlorthalidone-induced hyperosmolar hyperglycemic nonketotic coma." JAMA 220 (1972): 1592-3
Domenet JG "Diabetogenic effect of oral diuretics." Br Med J 3 (1968): 188
Kansal PC, Buse J, Buse MG "Thiazide diuretics and control of diabetes mellitus." South Med J 62 (1969): 1372-9
"Product Information. Metahydrin (trichlormethiazide)." Hoechst Marion-Roussel Inc, Kansas City, MO.
"Product Information. HydroDIURIL (hydrochlorothiazide)." Merck & Co, Inc, West Point, PA.
"Product Information. Diuril (chlorothiazide)." Merck & Co, Inc, West Point, PA.
Jones IG, Pickens PT "Diabetes mellitus following oral diuretics." Practitioner 199 (1967): 209-10
Elmfeldt D, Berglund G, Wedel H, Wilhelmsen L "Incidence and importance of metabolic side-effects during antihypertensive therapy." Acta Med Scand Suppl 672 (1983): 79-83
Seltzer HS, Allen EW "Hyperglycemia and inhibition of insulin secretion during administration of diazoxide and trichlormethiazide in man." Diabetes 18 (1969): 19-28
Miller NR, Moses H "Transient oculomotor nerve palsy. Association with thiazide-induced glucose intolerance." JAMA 240 (1978): 1887-8
"Product Information. Lozol (indapamide)." Rhone-Poulenc Rorer, Collegeville, PA.